Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2011; 17(9): 1160-1166
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1160
Published online Mar 7, 2011. doi: 10.3748/wjg.v17.i9.1160
Table 1 Proton pump inhibitor types and equivalent doses used for maintenance therapy n (%)
| PPI types and doses | Acute phase | Maintenance phase |
| Esomeprazole 40 mg | 149 (26.94) | 10 (2.16) |
| Esomeprazole 20 mg | 20 (3.62) | 141 (30.45) |
| Omeprazole 20 mg | 314 (56.78) | 33 (7.13) |
| Omeprazole 10 mg | 1 (0.18) | 211 (45.57) |
| Lansoprazole 30 mg | 13 (2.35) | 4 (0.86) |
| Lansoprazole 15 mg | 1 (0.18) | 14 (3.02) |
| Pantoprazole 40 mg | 39 (7.05) | 1 (0.22) |
| Pantoprazole 20 mg | 1 (0.18) | 35 (7.56) |
| Rabeprazole 20 mg | 15 (2.71) | 1 (0.22) |
| Rabeprazole 10 mg | 13 (2.81) |
- Citation: Pace F, Riegler G, Leone A, Dominici P, Grossi E, Group TES. Gastroesophageal reflux disease management according to contemporary international guidelines: A translational study. World J Gastroenterol 2011; 17(9): 1160-1166
- URL: https://www.wjgnet.com/1007-9327/full/v17/i9/1160.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i9.1160